A systematic review evaluating modern technological innovations in cardiovascular disease management identified 51 primary research investigations out of an initial pool of 100 examined records. Researchers Tejaswini Mohanty, Sujata Mohapatra, and Madhulika Yadav conducted the comprehensive evidence synthesis to evaluate how contemporary tools such as biosensors, 3D printing, artificial intelligence, machine learning, wearable technology, and mobile devices operate across cardiovascular care. Over recent decades, cardiovascular disease has emerged as a central paradigm of chronic medical conditions, prompting significant exploration into digital healthcare interventions.
To assemble the evidence base, the authors conducted a thorough literature search following the PRISMA 2020 criteria across multiple indexing databases, including Scopus, PubMed, Web of Science, and Google Scholar. The screening and formal validity assessment excluded 37 review papers and 12 non-relevant publications from the initial collection of 100 studies. The remaining 51 primary research articles met the protocol criteria for detailed analytical evaluation regarding technological integration in cardiac healthcare delivery.
The synthesized evidence revealed substantial diversity across study methodologies, encompassing experimental, observational, and clinical study designs tied to cardiac technologies. The investigated innovations demonstrate functional potential to alter overall healthcare delivery mechanisms, expand direct patient participation, and improve health results. Furthermore, the review noted that these advanced tools may enhance the overall precision, effectiveness, and efficacy of cardiovascular disease management protocols.
Despite positive clinical capabilities, the authors emphasized critical barriers that continue to restrict broad deployment. The primary literature demonstrated marked heterogeneity across study designs, patient populations, and clinical outcomes, paired with lower clinical validity across multiple evaluations. These structural factors currently limit the widespread applicability of emerging digital interventions across mainstream cardiovascular healthcare environments.
In addition to methodology constraints, the investigators highlighted practical challenges surrounding practical adoption. Substantial issues involving implementation cost, rigorous regulatory requirements, robust clinical validation, and ease of access remain prominent considerations for expanding these technologies across health systems. The authors concluded that addressing these technological and systemic hurdles is necessary before biosensors, machine learning models, and related tools achieve broad clinical applicability.
The synthesis illustrates both the therapeutic opportunities and current evidentiary gaps characterizing modern cardiovascular technology. While smart mobile devices and analytical algorithms offer paths toward precise disease monitoring, practical execution remains bounded by heterogeneous study quality and rigorous validation standards across diverse patient cohorts.
The systematic review specifically examined how advanced tools—including biosensors, 3D printing, artificial intelligence, machine learning, wearable technology, and mobile devices—are being integrated to transform the landscape of cardiovascular healthcare. Published in Discover Applied Sciences, the review was structured to evaluate both the distinct therapeutic advantages and the practical constraints across these varied technological modalities.
By conducting a structured search using Scopus, PubMed, Web of Science, and Google Scholar under PRISMA 2020 guidelines, the investigation systematically narrowed the relevant medical literature. The authors noted that technological integration holds the potential to significantly enhance healthcare precision and patient engagement, but achieving routine clinical implementation requires resolving ongoing challenges surrounding cost, regulatory compliance, access, and rigorous clinical validation.
Subject of Research: Emerging technologies and digital tools in cardiovascular disease management
Article Title: A systematic review on emerging technologies for cardiovascular disease management
Article References: Mohanty, T., Mohapatra, S., & Yadav, M. (2026). A systematic review on emerging technologies for cardiovascular disease management. Discover Applied Sciences. https://doi.org/10.1007/s42452-026-09891-5
Image Credits: AI Generated
DOI: 10.1007/s42452-026-09891-5
Keywords: Cardiovascular Disease, Systematic Review, Artificial Intelligence, Biosensors, Machine Learning, Wearable Technology, Mobile Health, 3D Printing, PRISMA 2020, Digital Health, Clinical Validity, Chronic Disease Management, Healthcare Delivery, Medical Technology, Patient Monitoring, Clinical Evidence
News Source: Frances Kline. (November 12, 2026). Systematic Review Evaluates Emerging Digital Technologies for Cardiovascular Disease Management. Scienmag.



